Translational value of mouse models in oncology drug development
Top Cited Papers
- 7 May 2015
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 21 (5), 431-439
- https://doi.org/10.1038/nm.3853
Abstract
Much has been written about the advantages and disadvantages of various oncology model systems, with the overall finding that these models lack the predictive power required to translate preclinical efficacy into clinical activity. Despite assertions that some preclinical model systems are superior to others, no single model can suffice to inform preclinical target validation and molecule selection. This perspective provides a balanced albeit critical view of these claims of superiority and outlines a framework for the proper use of existing preclinical models for drug testing and discovery. We also highlight gaps in oncology mouse models and discuss general and pervasive model-independent shortcomings in preclinical oncology work, and we propose ways to address these issues.Keywords
This publication has 86 references indexed in Scilit:
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Stage-specific sensitivity to p53 restoration during lung cancer progressionNature, 2010
- Selective activation of p53-mediated tumour suppression in high-grade tumoursNature, 2010
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003